We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$28.2B
1-Year Est. Return
115.26%
This Fund
S&P 500
This Quarter
Est. Return
-16.7%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
–
AUM
$17M
AUM Growth
-$5.13M
(-23%)
Cap. Flow
+$204M
Cap. Flow
% of AUM
1,200.25%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
157
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$108M |
| 2 |
Visa
V
|
+$102M |
| 3 |
Mercado Libre
MELI
|
+$73M |
| 4 |
Enphase Energy
ENPH
|
+$58.6M |
| 5 |
Snowflake
SNOW
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$116M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
| 4 |
Apple
AAPL
|
+$98.2M |
| 5 |
NVIDIA
NVDA
|
+$95.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Industrials | 25.1% |
| 3 | Healthcare | 17.44% |
| 4 | Financials | 14.92% |
| 5 | Communication Services | 5.35% |
Similar funds
N
TWC
FDCDDQ
NA
Polar Capital Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, Polar Capital Holdings held 494 positions worth $17M, down 23% from $22.2M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Polar Capital Holdings deployed $204M of net new capital in Q2 2022, opening 36 new positions and adding to 156 existing holdings. Its largest new stake was Sanofi: 725,000 shares worth $36.3K.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Applied Materials, an estimated $116M trimmed.
- Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3K.
- Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
- Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
- Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147K.
- Polar Capital Holdings's ten largest holdings make up 43% of its $17M portfolio in Q2 2022.
- Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
- Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17M.
Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.